{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:25:30Z","timestamp":1789770330236,"version":"4.0.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/jac\/dkx275","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T19:14:21Z","timestamp":1499800461000},"page":"3167-3171","source":"Crossref","is-referenced-by-count":11,"title":["Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals"],"prefix":"10.1093","volume":"72","author":[{"given":"Minh P","family":"L\u00ea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Belarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Dulioust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Peytavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"key\n\t\t\t\t20171023155420_dkx275-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1310\/WMWL-6W9Y-PXV2-X148","article-title":"Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations","volume":"3","year":"2002","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00126334-200304010-00018","article-title":"HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen","volume":"32","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B3","doi-asserted-by":"crossref","first-page":"e1001053.","DOI":"10.1371\/journal.ppat.1001053","article-title":"HIV-1 populations in semen arise through multiple mechanisms","volume":"6","year":"2010","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.43.8.1817","article-title":"Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1","volume":"43","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QAI.0b013e3181ae69c5","article-title":"Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women","volume":"51","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B6","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1097\/QAD.0b013e328270385a","article-title":"Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis","volume":"21","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/527387","article-title":"Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B8","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.01460-10","article-title":"Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/AAC.48.2.632-634.2004","article-title":"Differential diffusions of indinavir and lopinavir in genital secretions of human immunodeficiency virus-infected women","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B10","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1128\/AAC.06474-11","article-title":"Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/bmc.865","article-title":"Simultaneous determination of 17 antiretroviral drugs in human plasma for quantitative analysis with liquid chromatography-tandem mass spectrometry","volume":"21","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2125.2008.03140.x","article-title":"Population pharmacokinetic\/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients","volume":"65","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/QAI.0b013e31802b4956","article-title":"Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals","volume":"43","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1310\/hct1405-216","article-title":"Efficacy and safety 48\u2009weeks after switching from efavirenz to rilpivirine using emtricitabine\/tenofovir disoproxil fumarate-based single-tablet regimens","volume":"14","year":"2013","journal-title":"HIV Clin Trials"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3851\/IMP1919","article-title":"Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract","volume":"16","year":"2011","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3851\/IMP2750","article-title":"Pharmacokinetics of raltegravir in the semen of HIV-infected men","volume":"19","year":"2014","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B17","first-page":"281","article-title":"Protein content of human seminal plasma and spermatozoa in relation to sperm counts","volume":"7","year":"1976","journal-title":"Acta Eur Fertil"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.urology.2012.06.027","article-title":"Study of sperm protein profile in men with and without varicocele using two-dimensional gel electrophoresis","volume":"81","year":"2013","journal-title":"Urology"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B19","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1093\/jac\/dkv113","article-title":"Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study","volume":"70","author":"on behalf of the ROCnRAL ANRS 157 Study Group","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171023155420_dkx275-B20","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/cid\/ciu187","article-title":"HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens","volume":"58","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/11\/3167\/21359408\/dkx275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T15:08:53Z","timestamp":1569769733000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/72\/11\/3167\/4107866\/Penetration-and-antiviral-efficacy-of-total-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,9,8]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx275","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,9,8]]}}}